Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

MENA

Digital pharma marketing: 5 ways to avoid localisation problems

Localisation of digital materials isn’t difficult but it can go wrong. Here’s how to keep everything on track.

Anthill Agency

- PMLiVE

Duchenne UK and pharma partner pilot data-sharing HTA approach

Pfizer, Roche and PTC Therapeutics are among those participating in Project Hercules

Digital marketing: how to build internal support

Many problems with digital communications can be traced back to internal communications. Here’s how to get the support your need.

Anthill Agency

Are you providing the kind of content that affiliates want? 5 questions to answer.

To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning core materials.

Anthill Agency

How to provide affiliate-friendly content

To ensure that your core content gets used by affiliates, empowerment is key. Here are two simple strategies to achieve it.

Anthill Agency

Webinar: Portfolio tracking for success

Thursday 18th January 2018 11:00 EST / 16:00 GMT / 17:00 CEST

Research Partnership

Patient involvement in health technology assessment

Patients can improve the quality, relevance and value of HTA for all pharma stakeholders

The kind of data that affiliates want

The right kind of data builds affiliate support for international digital marketing.

Anthill Agency

The big dilemma in international digital pharma marketing

How to get consistent international marketing while meeting local affiliates’ needs.

Anthill Agency

- PMLiVE

Exploring serious market access roadblocks for rare bleeding disorders

Ensuring that sufferers get the treatment they require

Why I think rare disease companies are more patient-centric

Guest blogger Kamlesh Sheth believes companies that specialise in rare disease tend to be more patient-centric.

Say Communications

Roche Basel Switzerland

Roche claims its own CAR-T first with orphan drug Actemra

Comes as FDA approves the first CAR-T therapy from Novartis

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links